Please select a HGH news story from the list below:
January 22, 2008 -- BRISBANE, Calif. -- Tercica, Inc. (NASDAQ: TRCA) today announced that the Company has begun dosing the first patient in a Phase II clinical study...
December 6, 2007 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c76537) has announced the addition of new Decision Resources...
October 24, 2007 -- October 25-26, Barcelo Sants Hotel, Barcelona SAN FRANCISCO -- Osteologix Inc. (OTCBB:OLGX) today announced that Philip J. Young, President and CEO...
August 31, 2007 -- Somatuline([R]) Depot Becomes the First Product Originating from Ipsen's R&D to Be Approved by the FDA and Marketed Globally(1) PARIS --...
August 29, 2007 -- * Increased effort in Research & Development * Results in line with management expectations: full year 2007 operating margin guidance confirmed...
August 9, 2007 -- PARIS -- Regulatory News: Increlex([R]) is the First Recombinant Human Insulin-Like Growth Factor-1 Therapy Approved in Europe for Severe Primary...
August 2, 2007 -- --Company Increases Increlex 2007 Revenue Guidance-- BRISBANE, Calif. -- Tercica, Inc. (Nasdaq:TRCA) today announced financial results for the...
August 1, 2007 -- * +7.6% growth in Group sales, +9.3% growth in volume sold * Continued growth outside the Major Western European Countries: +16.2% * Strong...
July 10, 2007 -- Combination Products for the Potential Treatment of Short Stature and Adult Growth Hormone Deficiency Tercica May Receive up to $53 Million in...
May 25, 2007 -- PARIS -- Regulatory News: Upon marketing authorization, Increlex([R] )will be commercialized in the European Union by Ipsen, Tercica's partner...
Our goal is to spread human growth hormone information in the form of general information and useful HGH articles from a wide variety of print publications.
If we've proved to be a useful resource why not now?
designed: expert answers